Literature DB >> 9674936

Neurobiology of lithium: an update.

R H Lenox1, R K McNamara, R L Papke, H K Manji.   

Abstract

Lithium remains a first-line approach for the treatment of acute mania and the prophylactic management of manic-depressive illness, yet the underlying neurobiological mechanisms remain as yet undefined. In this paper we critically examine the accumulated preclinical and clinical evidence for the action of lithium in the brain and suggest areas that may be most productive for future investigation, i.e., membrane transport systems, neurotransmitter receptor regulation, second messenger generating systems, protein kinase C (PKC) regulation, and gene expression. In their experimental design, preclinical investigations have often jeopardized the physiologic relevance of their studies by a relative lack of attention to issues such as therapeutic concentrations, acute versus chronic exposure, and a lack of adequate cation and/or psychotropic controls. Future studies should account for the established prophylactic efficacy of lithium, the higher risk for relapse into mania after abrupt discontinuation, the ability of lithium to stabilize recurrent depression associated with unipolar disorder, and the efficacy of lithium in the treatment of refractory major depressive disorder in the presence of an antidepressant. Studies of the action of lithium in receptor mediated phosphoinositide signaling in the brain over the past several years have opened up heuristic lines of investigation that stem from lithium's uncompetitive inhibition of the enzyme inositol monophosphatase. Subsequent studies involving regulation of inositol transport, PKC isozymes and activity, and the expression of the major PKC substrate MARCKS (myristoylated alanine-rich C-kinase substrate) have offered potential avenues for understanding the complexity of the action of long-term lithium in the brain. These studies will offer us a better understanding of the neuroanatomical sites of action of lithium and together with ongoing clinical investigations using brain imaging in patients with manic-depressive illness a more complete understanding of the pathophysiology of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674936

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  A 4-year study of lithium intoxication reported to the Czech Toxicological Information Centre.

Authors:  Martina Krenová; Daniela Pelclová
Journal:  Pharm World Sci       Date:  2006-11-17

2.  P2Y(2) receptors and water transport in the kidney.

Authors:  Bellamkonda K Kishore; Raoul D Nelson; R Lance Miller; Noel G Carlson; Donald E Kohan
Journal:  Purinergic Signal       Date:  2009-03-25       Impact factor: 3.765

3.  Real-time particle-by-particle detection of erythrocyte-camouflaged microsensor with extended circulation time in the bloodstream.

Authors:  Wenjun Di; Xuefei Tan; Isen Andrew C Calderon; Ashlyn E Neal Reilly; Mark Niedre; Heather A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

4.  Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate.

Authors:  R S Williams; M Eames; W J Ryves; J Viggars; A J Harwood
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

5.  Inositol monophosphatase regulates localization of synaptic components and behavior in the mature nervous system of C. elegans.

Authors:  Yoshinori Tanizawa; Atsushi Kuhara; Hitoshi Inada; Eiji Kodama; Takafumi Mizuno; Ikue Mori
Journal:  Genes Dev       Date:  2006-12-01       Impact factor: 11.361

Review 6.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

7.  Potential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidus.

Authors:  Yue Zhang; Raoul D Nelson; Noel G Carlson; Craig D Kamerath; Donald E Kohan; Bellamkonda K Kishore
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-25

Review 8.  Lithium therapy and hyperparathyroidism: an evidence-based assessment.

Authors:  Brian D Saunders; Erika F H Saunders; Paul G Gauger
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.